Skip to main content

Cervarix

Product overview

Type
Human Papillomavirus (Bivalent)
Commercial Name
Cervarix
Manufacturer
GlaxoSmithKline Biologicals SA
Responsible NRA
Federal Agency for Medicines and Health Products
Country
Belgium

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
1
Diluent
Not Applicable
Route of Administration
Intramuscular
Shelf Life
60 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
a. Carton of 1 vial [Dimensions 3.1x3.1x6.0 cm]; b. Carton of 10 vials [Dimensions 8.4x3.7x3.7 cm]; c. Carton of 100 vials [Dimensions 17.8x14.7x3.7]
Tertiary Packaging
Box of 24 cartons of 100 vials (2400 doses) [Dimensions 34x25x43 cm]
Multidose Vial Policy
Not Applicable.
Vaccine Preservative
none
Cold Chain Volume
a)57.7; b)11.5; c)9.7 cm3/dose (in secondary packaging)

Attachments

Container Photo
Container Photo (Bigger\ Higher Resolution)
Package Insert
Package Insert